BioPlus Acquisition
BIOS | NASDAQ
$10.79
-$0.01 (-0.09%)
At close: Oct 06, 2023, 03:46 PM ET
-0.09%
(1D)Rating
Key Statistics
Market Data
Market Cap $209.07M
1D Range
10.79 10.80
52W Range
10.12 11.68
Valuation (TTM)
PE 35.97
PB 1.72
EV/EBITDA -99.13
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target N/A
Cash Flow
FCF Yield -0.8%
SBC Adj. FCF Yield -0.8%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-75.8%
Dil EPS 3Y | 5Y 161.9% |
170.1%
FCF 3Y | 5Y -128.2% |
21.5%
Returns
ROA 2.2%
ROE 2.3%
ROIC -0.5%
Financial Health
Net Debt
$5.25M
Current Ratio 1.04
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Currently, BioPlus Acquisition Corp. possesses no major active business operations. Its express mandate is to pursue and complete a strategic combination, which may take the form of a merger, share ex...
Sector Financial Services
Industry Shell Companies
Employees n/a
IPO Date Jan 28, 2022
Website bioplusspac.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BIOS